Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-27
DOI
10.1038/s41541-018-0094-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles
- (2018) Sachin G. Thakkar et al. JOURNAL OF DRUG TARGETING
- Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses
- (2018) Emilie Seydoux et al. JOURNAL OF IMMUNOLOGY
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
- (2017) Wivine Burny et al. Frontiers in Immunology
- IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants
- (2016) Anthony L. Desbien et al. JOURNAL OF IMMUNOLOGY
- Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice
- (2016) Karen K. Yam et al. VACCINE
- Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles
- (2016) Tinashe B. Ruwona et al. VACCINE
- Regulation of inflammasome activation
- (2015) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection
- (2015) M. Gaya et al. SCIENCE
- Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ
- (2014) Anthony L. Desbien et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?
- (2014) James D Cherry Expert Review of Vaccines
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- The impact of size on particulate vaccine adjuvants
- (2014) Ruchi R Shah et al. Nanomedicine
- Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles
- (2013) Bingbing Sun et al. ACS Nano
- Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
- (2013) Mark T. Orr et al. JOURNAL OF CONTROLLED RELEASE
- Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
- (2013) Xinran Li et al. JOURNAL OF CONTROLLED RELEASE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
- (2013) M. Vono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
- (2012) Yufei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
- (2012) Nicola P. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- Antigen depot is not required for alum adjuvanticity
- (2011) Sharon Hutchison et al. FASEB JOURNAL
- Alhydrogel® adjuvant, ultrasonic dispersion and protein binding: A TEM and analytical study
- (2011) J. Robin Harris et al. MICRON
- DNA released from dying host cells mediates aluminum adjuvant activity
- (2011) Thomas Marichal et al. NATURE MEDICINE
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo
- (2010) M. W. Munks et al. BLOOD
- Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design
- (2010) Xinran Li et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer
- (2010) George Krashias et al. VACCINE
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Immunology of TLR-independent vaccine adjuvants
- (2009) Ennio De Gregorio et al. CURRENT OPINION IN IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More